1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. Calendar
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
Delayed London Stock Exchange  -  11:35 2022-08-05 am EDT
10866.00 GBX   +1.36%
08/06Daiichi Sankyo and AstraZeneca’s Enhertu® Receives Approval in the U.S. as the First HER2 Directed Therapy for Patients with HER2 Low Metastatic Breast Cancer
CI
08/05ENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the US as the first HER2-directed therapy for patients with HER2-low metastatic breast cancer
BU
08/05ASTRAZENECA : Enhertu approved in the US as the first HER2-directed therapy for patients with HER2-low metastatic breast cancer
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Event chart ASTRAZENECA PLC
Upcoming events on ASTRAZENECA PLC
08/11/22 Ex-dividend day for interim dividend
11/10/22 Q3 2022 Earnings Release (Projected)
02/02/23 FY 2022 Earnings Release (Projected)
04/28/23 Q1 2023 Earnings Release (Projected)
07/27/23 Interim 2023 Earnings Release (Projected)
Past events on ASTRAZENECA PLC
08/04/22 Roadshow
08/04/22 Roadshow
08/03/22 Roadshow
08/03/22 Roadshow
08/03/22 Roadshow
08/03/22 Roadshow - Day 2
08/02/22 Roadshow
08/02/22 Roadshow - Day 1
08/02/22 Roadshow
08/02/22 Roadshow
Past dividends on ASTRAZENECA PLC
02/24/22 Final Payment 1.453 GBP
08/12/21 Interim Payment 0.648 GBP
02/25/21 Final Payment 1.374 GBP
08/13/20 Interim Payment 0.696 GBP
02/27/20 Final Payment 1.464 GBP
08/08/19 Interim Payment 0.719 GBP
02/28/19 Final Payment 1.468 GBP
08/09/18 Interim Payment 0.684 GBP
02/15/18 Final Payment 1.336 GBP
08/10/17 Interim Payment 0.689 GBP
Annual results
Fiscal Period : December201720182019202020212022
Sales
M $
Released
Forecast
Spread
22 465
22 117
1,6%
22 090
22 157
-0,30%
24 384
24 440
-0,23%
26 617
26 378
0,91%
37 417
36 239
3,2%
 
44 198
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
6 713
6 604
1,7%
7 140
6 767
5,5%
6 686
6 882
-2,8%
8 311
8 087
2,8%
7 586
10 816
-30%
 
13 767
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
6 855
6 450
6,3%
5 672
5 897
-3,8%
6 436
6 631
-2,9%
7 340
7 417
-1,0%
9 928
10 003
-0,75%
 
13 758
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
2 227
2 602
-14%
1 993
2 712
-27%
1 548
2 081
-26%
3 916
4 387
-11%
-265
1 510
-118%
 
4 999
 
Net income
M $
Released
Forecast
Spread
3 001
2 477
21%
2 155
2 306
-6,6%
1 335
1 895
-30%
3 196
2 930
9,1%
112
2 055
-95%
 
4 471
 
EPS
$
Released
Forecast
Spread
2,37
1,90
25%
1,70
1,79
-4,8%
1,03
1,41
-27%
2,44
2,50
-2,3%
0,08
1,99
-96%
 
2,80
 
Announcement Date02/02/201802/14/201902/14/202002/11/202102/10/2022-
Quarterly results
Fiscal Period : December2021 Q22021 Q32021 Q42022 Q12022 Q22022 Q3
Sales
M $
Released
Forecast
Spread
8 220
7 450
10%
9 866
9 580
3,0%
12 011
11 061
8,6%
11 390
10 967
3,9%
10 771
10 577
1,8%
 
10 852
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
1 880
2 171
-13%
1 114
3 056
-64%
1 900
4 512
-58%
2 187
3 894
-44%
1 896
5 337
-64%
 
2 887
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
1 805
1 763
2,4%
2 281
2 674
-15%
3 318
3 291
0,82%
3 961
3 486
14%
3 365
3 291
2,2%
 
3 262
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
764
705
8,3%
-2 001
1 485
-235%
-636
1 321
-148%
553
972
-43%
247
580
-57%
 

 
Net income
M $
Released
Forecast
Spread
550
482
14%
-1 652
1 269
-230%
-347
908
-138%
386
1 086
-64%
360
946
-62%
 
1 774
 
EPS
$
Released
Forecast
Spread
0,42
0,37
14%
-1,10
0,85
-230%
-0,22
0,62
-135%
0,25
0,70
-64%
0,23
0,78
-71%
 
0,46
 
Announcement Date07/29/202111/12/202102/10/202204/29/202207/29/2022-
Previous year Next Year
Upcoming sector events for ASTRAZENECA PLC
More events
Past sector events for ASTRAZENECA PLC
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise